Data / Form D filings / ORTHOCON INC
ORTHOCON INC: Form D filing
ORTHOCON INC, a biotechnology company in North Brunswick, NJ, filed a Form D with the SEC in 2009. The latest, on April 10, 2009, reports $10.5 million sold of a $25 million offering to 8 investors.
Find out what ORTHOCON INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 675 US Highway One, North Brunswick, NJ, 08902
- Phone
- (732) 418-0025
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- De
- Year incorporated
- 2005
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1446928
The full lists. Form D filings in New Jersey: 714 rows, $35.70, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 10, 2009 | New notice | $24,999,937 | $10,499,949 | $14,499,988 | 8 | Mar 19, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Alan Levy, Ph.D | Director | |
| John Pacifico | Executive Officer | |
| Paul Sohmer, M.D. | Executive Officer, Director | |
| Seth Rudnick, M.D. | Director | |
| David Knaack | Executive Officer | |
| Klaus Breiner, Ph.D | Director | |
| Richard Kronenthal, Ph.D | Executive Officer | |
| Joyce Tsang, Ph.D | Director |
Other biotechnology companies in New Jersey that filed recently
- Ensho Therapeutics, Inc. $7.3 million · Oct 15, 2026
- Xenon Ophthalmics Inc $3.3 million · Oct 6, 2026
- LISATA THERAPEUTICS, INC. $351.9 million · Oct 2, 2026
Every Form D from the week of Apr 6, 2009 · All recent filings in New Jersey · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what ORTHOCON INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.